Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis

Journal of the International AIDS Society(2020)10.1002/jia2.25477Source: DataRank Database

Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis is a dataset published in Journal of the International AIDS Society (2020). On theSindex it has a DataRank of 0.969, placing it in the top 20.9% of the data-sharing corpus. It has been cited 9 times, with 9 citing works in its 1-hop citation network.

Top 21%percentile

0.969DataRank

Ranks in the top 21% for downstream scientific impact

Data paper Open Access9 citations · 9 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (44 grants)Impact (FWCI 0.15)OA: goldTopics (75)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 36%Citation Network 64%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

0.624

From 8 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 9 citers.

Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV
Journal of the International AIDS Society202135 citations16 referencesContributes 0.224
Second-line tenofovir alafenamide for children with HIV in Africa
medRxiv20243 citations7 referencesContributes 0.198
HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya
JAIDS Journal of Acquired Immune Deficiency Syndromes202124 citations37 referencesContributes 0.087
Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis
Journal of the International AIDS Society20209 citations28 referencesContributes 0.082
Clinical, immunologic and virologic outcomes of children and adolescents receiving second line anti-retroviral therapy in two referral hospitals in Addis Ababa, Ethiopia
PLoS ONE20213 citations25 referencesContributes 0.055

Authors (6)

Boulle, Andrew,Malisita, Kennedy,Fatti, Geoffrey,Haas, Andreas,Davies, Mary-Ann

Live enrichment

PubMed:32297485 PMC:PMC7160415 OpenAlex:https://openalex.org/W3016627384

National Institutes of Health

Grant: HHSN267200800001C

National Institutes of Health

Grant: N01‐3‐3345

National Institutes of Health

Grant: U01A1069911

National Institutes of Health

Grant: U01AI069907

National Institutes of Health

Grant: U01AI069919

National Institutes of Health

Grant: U01AI069923

National Institutes of Health

Grant: U01AI069924

National Institutes of Health

Grant: U01AI096299

National Institutes of Health

Grant: U01AI41110

National Institutes of Health

Grant: U01HD052102

National Institutes of Health

Grant: U01HD052104

National Institutes of Health

Grant: UM1AI068616

National Institutes of Health

Grant: UM1AI068632

National Institutes of Health

Grant: UM1AI106716

Medical Research Council

Grant: MC_UU_12023/26

Paediatric and adolescent infections

Centers for Disease Control and Prevention

Grant: 5U2GPS001537

Centers for Disease Control and Prevention

Grant: 5U62PS223540

Instituto de Salud Carlos III

Grant: RD12/0017/0035

Instituto de Salud Carlos III

Grant: RD12/0017/0037

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Grant: 148522

Swiss HIV Cohort Study (SHCS)

NIDDK NIH HHS

Grant: HHSN267200800001G

NIAID NIH HHS

Grant: U01 AI069911

NCHHSTP CDC HHS

Grant: U62 PS223540

Medical Research Council

Grant: MC_UU_12023/17

NIAID NIH HHS

Grant: U01 AI041110

NCHHSTP CDC HHS

Grant: U2G PS001537

National Institutes of Health

Grant: 5U01AI069907-13

IeDEA Asia-Pacific Research Collaboration

National Institutes of Health

Grant: 5U01AI069924-13

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)

National Institutes of Health

Grant: 5U01HD052104-15

Pediatric HIV/AIDS Cohort Study (PHACS) Coordinating Center (CC) (U01)

National Institutes of Health

Grant: 5UM1AI106716-07

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center

National Institutes of Health

Grant: 3U01AI096299-02S1

Central Africa IeDEA

National Institutes of Health

Grant: 5U01AI069919-13

IeDEA West Africa Renewal 3

National Institutes of Health

Grant: 5UM1AI068616-14

SDMC - IMPAACT Leadership Group

National Institutes of Health

Grant: 5U01AI041110-08

Statistical/Data Management Center-Pediatric AIDS CTG

National Institutes of Health

Grant: 5U62PS223540-07

RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR

National Institutes of Health

Grant: 5U01HD052102-15

Pediatric HIV/AIDS Cohort Study (PHACS): Data and Operations Center (DOC).

European Commission

Grant: 260694

European Network of HIV/AIDS Cohort Studies to Coordinate at European and International Level Clinical Research on HIV/AIDS

National Institutes of Health

Grant: 3U01AI069923-04S1

CCASAnet: Caribbean, Central and South America Network

National Institutes of Health

Grant: 7UM1AI068632-07

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group

National Institutes of Health

Grant: 5U2GPS001537-05

PS09-904 TECHNICAL ASSISTANCE IN SUPPORT OF HIV PREVENTION, CARE AND TREATMENT

European Regional Development Fund

GlaxoSmithKline

Roche

Bristol-Myers Squibb

FWCI

0.15

Citation Percentile

0.6%

Citation Trend

2020

2021

2022

2024

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25477

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jia2.25477

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjia2.25477

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25477

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/jia2.25477

Fields of Study

HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsMobile Health and mHealth Applications03 medical and health sciences0302 clinical medicineAnti-Retroviral AgentsCD4 Lymphocyte CountChildChild, PreschoolCohort StudiesFemaleGlobal HealthHIV InfectionsHumansIncidenceMaleTreatment FailureTreatment Outcome

MeSH Terms

ChildChild, PreschoolFemaleHumansMaleGlobal HealthCohort StudiesHIV InfectionsIncidenceTreatment OutcomeTreatment FailureCD4 Lymphocyte CountAnti-Retroviral Agents

Keywords

MedicineContext (archaeology)CohortAntiretroviral therapyRegimenDemographySecond linePediatricsLatin AmericansHuman immunodeficiency virus (HIV)Viral loadFirst lineInternal medicineFamily medicineGeographyMortalityChildrenOutcomesSecond-linePerinatal HivMaleInfection in childrenHIV InfectionsGlobal HealthCohort StudiesHIV, childrenVIH (Virus)HumansTreatment FailureChildResearch ArticlesHIV (Viruses)IncidenceAntiretroviralschildren perinatal HIV second-line antiretroviral therapy mortality outcomesAntiretroviral agentsCD4 Lymphocyte Count[SDV] Life Sciences [q-bio]Treatment OutcomeAnti-Retroviral AgentsChild, PreschoolFemalesecond‐lineInfeccions en els infants

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being